View Older Stories View More Recent Stories
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
ROSEN, A LEADING LAW FIRM, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Xerox
-
Volkswagen shares fall as markets struggles to digest unions deal
-
How Car Shipping Could Change Under Trump: Impact on the Industry and Economy
-
Europe's energy taxes are worsening industry woes, power CEO says
-
VW managers to get 10% pay cut in plan to slash bonuses, German newspaper reports
-
Stellantis reverses Ohio layoffs weeks after CEO's abrupt departure
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
VW, union agree to cut 35,000 jobs in Germany, avert strikes
-
Korea Zinc Union Mobilizes Resistance to MBK’s Hostile M&A, Urging Nationwide Support
-
RBC Capital Downgrades HOOKIPA Pharma Inc. (HOOK) to Sector Perform
-
VW reaches union deal to cut 35,000 German jobs after gruelling talks
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
GEE Group Announces Results for the Fiscal 2024 Full Year and Fourth Quarter
-
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
-
FuelCell Energy Reports Fourth Quarter and Full Fiscal Year 2024 Results
-
Bank of England more split than expected over December rate decision
-
Upwork Inc. (UPWK) PT Raised to $20 at Canaccord Genuity
-
Behind a potential Honda and Nissan tie-up, the existential threat posed by Chinese EVs
-
Labour shortages ease in Germany's economy, survey shows
-
German consumer sentiment outlook modest after slight pickup, GfK finds
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
Steelcase Reports Third Quarter Fiscal 2025 Results
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
Honda, Nissan in talks to set up holding company, source says
-
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Xerox
-
German business sentiment tumbles in December amid 'chronic' weakness
-
ROSEN, A LEADING LAW FIRM, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
Tennessee Workers Demand Accountability from Mersen, Call on Elected Officials to Act as Company Announces Holiday Layoffs Despite Record Financial Success
-
Protect Yourself: LegalMatch's Guide to Severance Packages
-
ROSEN, A LEADING LAW FIRM, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
Flagstar Bank (FLG) Appoints Brian Callanan to its Board
-
Flagstar Bank (FLG) Appoints Lee Smith as CFO
-
FLAGSTAR FINANCIAL, INC. NAMES LEE SMITH AS CHIEF FINANCIAL OFFICER
-
FLAGSTAR FINANCIAL, INC. APPOINTS BRIAN CALLANAN TO BOARD OF DIRECTORS
-
Chardan Capital Markets Downgrades Editas Medicine (EDIT) to Neutral
-
Trump advisers seek to shrink or eliminate bank regulators, WSJ reports
-
AiAdvertising Reports Nine Months Ended September 30, 2024 Financial Results
-
Editas Medicine (EDIT) Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years
-
Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - XRX
-
Rhino to Begin Offering 'Loss of Employment Protection' to Lend Financial Support to Renters Experiencing Challenging Times
-
Eggs boost US producer prices in November, but services inflation slowing
-
TuHURA Biosciences (HURA) Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
-
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
-
Baidu, Geely's EV venture faces uproar after it says needs fresh funds
-
Inside Boeing’s struggle to make its best-selling plane again

